Raj Makkar, MD, FSCAI, FACC

Vice President of Cardiovascular Innovation and Intervention
Cedars-Sinai Medical Center
Los Angeles, California, United States

Dr. Raj Makkar is the Vice President of Cardiovascular Innovation and Intervention and Director of Interventional Cardiology and Cardiac Catheterization Laboratory, Associate Director, Cedars-Sinai Heart Institute. He is an interventional cardiologist with over 25 years of experience in the field. His main research interest is valve disorders, stem cells and high risk PCI. He has performed a series of studies in this area and has conducted many clinical trials.

Disclosure information not submitted.

Presentation(s):

• Can We Randomize Patients With BICUSPID AS to SAVR Versus SAVR?

  Saturday, March 8, 2025
  10:47 AM – 10:55 AM ET

• Panel Discussion

  Saturday, March 8, 2025
  10:55 AM – 11:15 AM ET

• Panel Discussion | How Should We Proceed with Tricuspid Valve Interventions and When Should We Intervene?

  Saturday, March 8, 2025
  4:42 PM – 5:00 PM ET

• SAPIEN M3 TMVR Technology and Clinical Update

  Sunday, March 9, 2025
  9:51 AM – 9:58 AM ET

• Panel Discussion: What Is the Best Management of MR | Percutaneous Valve Repair or Replacement?

  Sunday, March 9, 2025
  11:40 AM – 12:05 PM ET

• Pascal Edge-to-Edge for Tricuspid Regurgitation

  Sunday, March 9, 2025
  3:53 PM – 4:01 PM ET

• Panel Discussion | Are we Ready for Repair and Replacement of Tricuspid Disease

  Sunday, March 9, 2025
  4:25 PM – 4:45 PM ET

• LATE-BREAKING CLINICAL SCIENCE | STRUCTURAL I

  Sunday, March 9, 2025
  2:15 PM – 3:30 PM ET

• Outcomes in the ALIGN-AR Continued Access Study for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

  Monday, March 10, 2025
  12:20 PM – 12:30 PM ET